Alcobra Ltd Company Profile (NASDAQ:ADHD)

About Alcobra Ltd (ADHD)

Alcobra Ltd logoAlcobra Ltd is an Israel-based Biopharmaceutical company. It focuses on the development and commercialization of a proprietary drug, MG01CI, to treat Attention Deficit Hyperactivity Disorder (ADHD), a common and morbid neuropsychiatric condition in children and adults. Adult ADHD is associated with increased health risks and healthcare costs, higher divorce rates, lower levels of socioeconomic attainment, lower academic achievement, unemployment and work place deficits, increased risks for motor vehicle accidents, greater likelihood of additional psychiatric disorders, increased criminal activity and incarceration, and higher rates of substance use and abuse. MG01CI product has completed phase two studies.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ADHD
  • CUSIP: N/A
Key Metrics:
  • Previous Close: $1.14
  • 50 Day Moving Average: $1.147
  • 200 Day Moving Average: $1.625
  • 52-Week Range: $0.83 - $5.75
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.38
  • P/E Growth: 0.000
  • Market Cap: $33.49M
  • Outstanding Shares: 27,562,000
  • Beta: 1.33
Profitability:
  • Return on Equity: -38.21%
  • Return on Assets: -36.62%
Debt:
  • Current Ratio: 15.99%
  • Quick Ratio: 15.99%

Analyst Ratings

Consensus Ratings for Alcobra Ltd (NASDAQ:ADHD) (?)
Ratings Breakdown: 1 Sell Rating, 6 Hold Ratings, 3 Buy Ratings
Consensus Rating:Hold (Score: 2.20)
Consensus Price Target: $2.02 (66.37% upside)

Analysts' Ratings History for Alcobra Ltd (NASDAQ:ADHD)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
4/13/2017Cantor FitzgeraldReiterated RatingHold$1.00LowView Rating Details
3/31/2017Jefferies Group LLCReiterated RatingHold$1.25LowView Rating Details
2/9/2017Roth CapitalUpgradeNeutral -> Buy$4.00N/AView Rating Details
1/17/2017Stifel NicolausSet Price TargetHold$2.00N/AView Rating Details
1/17/2017Oppenheimer Holdings Inc.Reiterated RatingHoldN/AView Rating Details
1/17/2017Piper Jaffray CompaniesSet Price TargetHold$3.00 -> $2.00N/AView Rating Details
11/2/2016WBB SecuritiesUpgradeSell -> Hold$4.00 -> $1.90N/AView Rating Details
10/28/2016Barclays PLCDowngradeEqual Weight -> Underweight$3.00 -> $2.00N/AView Rating Details
9/1/2016Goldman Sachs Group IncReiterated RatingBuyN/AView Rating Details
6/7/2016Canaccord GenuityInitiated CoverageBuyN/AView Rating Details
(Data available from 4/27/2015 forward)

Earnings

Earnings History for Alcobra Ltd (NASDAQ:ADHD)
Earnings by Quarter for Alcobra Ltd (NASDAQ:ADHD)
Earnings History by Quarter for Alcobra Ltd (NASDAQ:ADHD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/17/2017        
2/15/201712/31/2016($0.26)($0.22)ViewListenView Earnings Details
11/15/2016Q316($0.27)($0.28)$4.30 million$7.90 millionViewN/AView Earnings Details
8/30/2016Q216($0.22)($0.21)ViewListenView Earnings Details
5/16/2016Q116($0.22)($0.18)ViewListenView Earnings Details
2/17/2016Q415($0.24)($0.20)ViewListenView Earnings Details
11/12/2015Q315($0.31)($0.20)ViewN/AView Earnings Details
8/13/2015Q215($0.30)($0.24)ViewListenView Earnings Details
5/6/2015Q1 2015($0.31)($0.26)ViewN/AView Earnings Details
2/12/2015Q4($0.57)($0.50)ViewN/AView Earnings Details
11/17/2014Q3 14($0.61)($0.77)ViewN/AView Earnings Details
8/11/2014Q2($0.58)($0.57)ViewListenView Earnings Details
2/13/2014Q413($0.35)($0.45)ViewN/AView Earnings Details
11/7/2013Q313($0.28)ViewN/AView Earnings Details
8/6/2013Q213($0.06)($0.15)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Alcobra Ltd (NASDAQ:ADHD)
2017 EPS Consensus Estimate: ($0.71)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172($0.25)($0.15)($0.20)
Q2 20172($0.23)($0.13)($0.18)
Q3 20172($0.18)($0.14)($0.16)
Q4 20172($0.19)($0.15)($0.17)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Alcobra Ltd (NASDAQ:ADHD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Alcobra Ltd (NASDAQ:ADHD)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Alcobra Ltd (NASDAQ:ADHD)
Latest Headlines for Alcobra Ltd (NASDAQ:ADHD)
Source:
DateHeadline
globenewswire.com logoAlcobra Mails Proxy Materials for Extraordinary General Meeting of Shareholders - GlobeNewswire (press release)
globenewswire.com - April 24 at 3:21 PM
americanbankingnews.com logoAlcobra (ADHD) Receiving Somewhat Negative Media Coverage, AlphaOne Reports
www.americanbankingnews.com - April 24 at 11:48 AM
finance.yahoo.com logoAlcobra Mails Proxy Materials for Extraordinary General Meeting of Shareholders
finance.yahoo.com - April 24 at 11:00 AM
americanbankingnews.com logoAlcobra (ADHD) Receives Daily Coverage Optimism Rating of 0.31
www.americanbankingnews.com - April 20 at 10:39 AM
americanbankingnews.com logoZacks Investment Research Lowers Alcobra Ltd (ADHD) to Hold
www.americanbankingnews.com - April 18 at 9:57 PM
americanbankingnews.com logoAlcobra Ltd (ADHD) Expected to Post Earnings of -$0.20 Per Share
www.americanbankingnews.com - April 18 at 1:22 PM
americanbankingnews.com logoAlcobra (ADHD) Earns Coverage Optimism Rating of 0.18
www.americanbankingnews.com - April 17 at 10:08 AM
americanbankingnews.com logoZacks Investment Research Upgrades Alcobra Ltd (ADHD) to Buy
www.americanbankingnews.com - April 17 at 7:36 AM
americanbankingnews.com logoAlcobra (ADHD) Receiving Positive Media Coverage, Report Finds
www.americanbankingnews.com - April 14 at 1:54 PM
americanbankingnews.com logoAlcobra Ltd (ADHD) Given "Hold" Rating at Cantor Fitzgerald
www.americanbankingnews.com - April 13 at 9:20 PM
finance.yahoo.com logoExodus Capital is Summoning an Extraordinary General Meeting
finance.yahoo.com - April 12 at 12:11 PM
americanbankingnews.com logoAlcobra Ltd (ADHD) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - April 11 at 10:58 PM
americanbankingnews.com logoAlcobra Ltd (ADHD) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - April 10 at 8:51 PM
streetinsider.com logoAlcobra Ltd. (ADHD) Rejects Brosh Capital's Request to Hold Extraordinary General Meeting
www.streetinsider.com - April 7 at 3:21 PM
finance.yahoo.com logoTenax Therapeutics and Alcobra Find Rough Waters Ahead
finance.yahoo.com - April 7 at 3:21 PM
streetinsider.com logoAlcobra Ltd. (ADHD) Rejects Brosh Capital's Request to Hold ... - StreetInsider.com
www.streetinsider.com - April 7 at 6:30 AM
finance.yahoo.com logoAlcobra Provides Update on Request for Extraordinary General Meeting
finance.yahoo.com - April 7 at 6:30 AM
americanbankingnews.com logoAlcobra's (ADHD) Hold Rating Reiterated at Jefferies Group LLC
www.americanbankingnews.com - April 6 at 7:13 AM
americanbankingnews.com logoAlcobra Ltd (ADHD) Earns "Hold" Rating from Jefferies Group LLC
www.americanbankingnews.com - April 5 at 1:30 PM
americanbankingnews.com logoShort Interest in Alcobra Ltd (ADHD) Increases By 19.1%
www.americanbankingnews.com - April 4 at 3:48 PM
bizjournals.com logoResearch Reports Initiation on Biotech Stocks -- Alcobra, Cerus, 22nd Century, and Moleculin Biotech
www.bizjournals.com - April 3 at 3:32 PM
americanbankingnews.com logoAlcobra Ltd Expected to Post FY2017 Earnings of ($0.76) Per Share (ADHD)
www.americanbankingnews.com - April 3 at 10:08 AM
americanbankingnews.com logoAlcobra Ltd (ADHD) Earns Hold Rating from Jefferies Group LLC
www.americanbankingnews.com - March 31 at 6:18 PM
americanbankingnews.com logoCantor Fitzgerald Reiterates "Hold" Rating for Alcobra Ltd (ADHD)
www.americanbankingnews.com - March 28 at 9:19 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit against Alcobra Ltd.
finance.yahoo.com - March 28 at 3:18 PM
finance.yahoo.com logoDEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Alcobra, Ltd. To Contact The Firm
finance.yahoo.com - March 28 at 8:03 AM
streetinsider.com logoBrosh Capital Requests Extraordinary General Meeting at Alcobra (ADHD), Seeks to Remove Board in Full - StreetInsider.com
www.streetinsider.com - March 18 at 3:18 PM
finance.yahoo.com logoIMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Alcobra, Ltd., and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - March 18 at 1:42 AM
finance.yahoo.com logoBrosh Capital Delivers Extraordinary General Meeting Request To Alcobra And Issues Letter To Chairman
finance.yahoo.com - March 16 at 4:52 PM
finance.yahoo.com logo12:36 pm Alcobra stockholder Brosh Capital delivers letter to the co's Board requesting an 'Extraordinary General Meeting of Shareholders in order to remove the existing Board in full, and nominate its six highly-qualified directors'
finance.yahoo.com - March 16 at 4:52 PM
americanbankingnews.com logoAlcobra Ltd (ADHD) Downgraded to “Hold” at Zacks Investment Research
www.americanbankingnews.com - March 15 at 9:33 PM
finance.yahoo.com logoIMPORTANT INVESTOR NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alcobra, Ltd., and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - March 15 at 3:26 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Alcobra, Ltd. (ADHD) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
finance.yahoo.com - March 14 at 8:18 PM
americanbankingnews.com logoAlcobra Ltd (ADHD) Upgraded to “Buy” at Zacks Investment Research
www.americanbankingnews.com - March 14 at 8:31 AM
finance.yahoo.com logoIMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alcobra, Ltd., and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - March 9 at 3:22 PM
americanbankingnews.com logoZacks Investment Research Downgrades Alcobra Ltd (ADHD) to Hold
www.americanbankingnews.com - March 7 at 10:39 PM
americanbankingnews.com logoStock Analysts’ Updated EPS Estimates for March, 7th (ADHD, ADRO, AFLYY, AMRC, AMRS, APTS, ASBFY, CELP, CHOLY, CHSP)
www.americanbankingnews.com - March 7 at 10:39 PM
finance.yahoo.com logoAlcobra Ltd. to Participate in Upcoming Healthcare Conferences
finance.yahoo.com - March 7 at 3:21 PM
finance.yahoo.com logoINVESTOR ALERT: Lundin Law PC Announces an Investigation of Alcobra, Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - March 3 at 3:31 PM
globenewswire.com logoAlcobra to Host Investor Forum and Webcast on March 28 in New ... - GlobeNewswire (press release)
globenewswire.com - March 1 at 3:20 PM
finance.yahoo.com logoINVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Alcobra, Ltd. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
finance.yahoo.com - March 1 at 3:20 PM
finance.yahoo.com logoAlcobra to Host Investor Forum and Webcast on March 28 in New York City
finance.yahoo.com - March 1 at 8:31 AM
globenewswire.com logoIMPORTANT ALCOBRA LTD. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a ... - GlobeNewswire (press release)
globenewswire.com - February 25 at 3:17 PM
us.rd.yahoo.com logoIMPORTANT ALCOBRA LTD. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the Southern District of New York on behalf of purchasers of Alcobra Ltd.
us.rd.yahoo.com - February 24 at 8:20 PM
finance.yahoo.com logoGlancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Alcobra Ltd. Investors and Encourages Investors to Contact the Firm
finance.yahoo.com - February 24 at 3:19 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Alcobra, Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - February 24 at 3:19 PM
globenewswire.com logoSHAREHOLDER ALERT: Brower Piven Notifies Investors of Class ... - GlobeNewswire (press release)
globenewswire.com - February 24 at 9:47 AM
finance.yahoo.com logoThe Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Alcobra Ltd. Investors and Encourages Investors to Contact the Firm
finance.yahoo.com - February 23 at 8:21 PM
finance.yahoo.com logoIMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alcobra, Ltd., and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - February 23 at 8:21 PM
finance.yahoo.com logoINVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Alcobra, Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - February 23 at 3:20 PM

Social

Frequently Asked Questions for Alcobra Ltd (NASDAQ:ADHD)

What is Alcobra Ltd's stock symbol?

Alcobra Ltd trades on the NASDAQ under the ticker symbol "ADHD."

How were Alcobra Ltd's earnings last quarter?

Alcobra Ltd (NASDAQ:ADHD) issued its quarterly earnings data on Wednesday, February, 15th. The company reported ($0.22) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.26) by $0.04.

When will Alcobra Ltd make its next earnings announcement?

Alcobra Ltd is scheduled to release their next quarterly earnings announcement on Wednesday, May, 17th 2017.

Where is Alcobra Ltd's stock going? Where will Alcobra Ltd's stock price be in 2017?

10 brokerages have issued twelve-month price targets for Alcobra Ltd's stock. Their forecasts range from $1.00 to $4.00. On average, they expect Alcobra Ltd's share price to reach $2.02 in the next twelve months.

What are analysts saying about Alcobra Ltd stock?

Here are some recent quotes from research analysts about Alcobra Ltd stock:

  • 1. According to Zacks Investment Research, "Alcobra Ltd. is a biopharmaceutical company. It focuses on the development and commercialization of drugs to treat attention deficit hyperactivity disorder. Alcobra Ltd. is headquartered in Tel Aviv, Israel. " (4/18/2017)
  • 2. Cantor Fitzgerald analysts commented, "Development of new drugs carries a high failure rate, either because the drug in question fails to show efficacy or significant safety issues arise during the clinical trial process. In addition, regulatory authorities such as the Food & Drug Administration (FDA) may delay the approval process or reject Alcobra’s clinical findings." (4/13/2017)

Are investors shorting Alcobra Ltd?

Alcobra Ltd saw a increase in short interest in March. As of March 15th, there was short interest totalling 1,195,462 shares, an increase of 19.1% from the February 28th total of 1,003,520 shares. Based on an average daily trading volume, of 525,584 shares, the days-to-cover ratio is presently 2.3 days.

Who owns Alcobra Ltd stock?

Alcobra Ltd's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include EXODUS CAPITAL L.P. (16.80%), BROSH CAPITAL L.P. (12.00%), BROSH CAPITAL L.P. (10.90%), BROSH CAPITAL L.P. (9.40%) and BROSH CAPITAL L.P. (9.00%).

How do I buy Alcobra Ltd stock?

Shares of Alcobra Ltd can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Alcobra Ltd stock cost?

One share of Alcobra Ltd stock can currently be purchased for approximately $1.22.

Alcobra Ltd (ADHD) Chart for Thursday, April, 27, 2017

This page was last updated on 4/27/2017 by MarketBeat.com Staff